Moonpig Group Plc and its shareholders plan to raise as much as GBP 384 million ($524 million) in an initial public offering in London, part of a rush of European companies looking to capitalize on robust stock markets and pandemic-fueled sales growth. Moonpig is marketing as many as 113 million shares at 310 pence to 350 pence apiece, according to terms seen on January 26, 2021 by Bloomberg News. The sale could value the company at GBP 1 billion to GBP 1.2 billion after the IPO. The offer period will run through February 2, 2021, with the new stock slated to start trading the next day on the London Stock Exchange. The company said that it expects to be eligible for inclusion in the FTSE U.K. indexes after it lists. Two fund managers, BlackRock Inc. and Dragoneer Global Fund II LP, have agreed to invest GBP 80 million and GBP 50 million, respectively, in the IPO at the offering price, according to the terms. The deal comes amid a resurgence in IPO activity in London, with the market off to the strongest start to a year since 2008 after a Brexit agreement cleared uncertainty for domestic firms. Permira Holdings-backed Dr. Martens is also prepping a London listing. Existing shareholders of Moonpig can sell another 11 million shares if there's enough demand, which would boost the total deal size to GBP 422 million, the terms show. Citigroup Inc. (NYSE:C) and JPMorgan Chase & Co. (NYSE:JPM) are joint global coordinators, while HSBC Bank Plc, Jefferies International Ltd. and Numis Securities Ltd. are joint bookrunners.